Integral Health Asset Management’s Rezolute RZLT Stock Holding History

Integral Health Asset Management’s Portfolio RZLT Stock Details RZLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.6M	Sell	500,000 -1,500,000	-75%	-$5.57M	0.1%	88
2026 Q1	$6.1M	Hold	2,000,000	–	–	0.29%	71
2025 Q4	$4.72M	Hold	2,000,000	–	–	0.23%	71
2025 Q3	$18.8M	Buy	2,000,000 +200,000	+11%	+$1.33M	1.27%	23
2025 Q2	$8.03M	Buy	1,800,000 +1,300,000	+260%	+$4.83M	0.74%	40
2025 Q1	$1.45M	Hold	500,000	–	–	0.15%	76
2024 Q4	$2.45M	Buy	500,000 +250,000	+100%	+$1.26M	0.21%	74
2024 Q3	$1.21M	Buy	+250,000	New	+$1.15M	0.14%	65

Other funds holding RZLT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Integral Health Asset Management's RZLT Position: Q2 2026 in Review

Integral Health Asset Management reduced its Rezolute (RZLT) stake by 75% in Q2 2026, selling an estimated $5.57M and leaving 500,000 shares worth $2.6M. The position accounts for 0.1% of the portfolio, ranked #88.

Integral Health Asset Management first reported a position in RZLT in Q3 2024 and has held it in 8 quarters since. The position peaked at $18.8M in Q3 2025. 144 funds tracked by Wall St. Rank hold RZLT as of Q2 2026.

Integral Health Asset Management held 500,000 shares of Rezolute worth $2.6M as of Q2 2026.
Integral Health Asset Management sold 1,500,000 Rezolute shares in Q2 2026, an estimated $5.57M.
Rezolute made up 0.1% of Integral Health Asset Management's portfolio in Q2 2026, its #88 holding.
Integral Health Asset Management first reported a position in Rezolute in Q3 2024 and has held it in 8 quarters since.
Integral Health Asset Management's Rezolute position peaked at $18.8M in Q3 2025.
144 funds tracked by Wall St. Rank held Rezolute as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.